SALIX PHARMACEUTICALS LTD·4

Jun 13, 4:33 PM ET

SALIX PHARMACEUTICALS LTD 4

4 · SALIX PHARMACEUTICALS LTD · Filed Jun 13, 2005

Insider Transaction Report

Form 4
Period: 2005-06-09
Taylor David N MD
VP - Chief Medical Officer
Transactions
  • Award

    Option to Buy Common Stock

    2005-06-09+10,50010,500 total
    Exercise: $17.63Exp: 2015-06-09Common Stock (10,500 underlying)
Holdings
  • Option to Buy Common Stock

    Exercise: $22.76Exp: 2014-09-01Common Stock (100,000 underlying)
    100,000
Footnotes (2)
  • [F1]Option vests at a rate of 1/48th per month, with a vesting commencement date of July 1, 2005.
  • [F2]Option vests monthly over 48 months, with a 1/4 of the shares vesting on September 1, 2005 and the remainder vesting at a rate of 1/48th per month thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION